TScan Therapeutics Appoints Gavin MacBeath, Ph.D. as Chief Executive Officer and as a Member of the Board of Directors May 25, 2023
TScan Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update May 10, 2023
Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease May 9, 2023
TScan Therapeutics Announces Upcoming Trial in Progress Poster Presentation at the American Society of Gene and Cell Therapy 26th Annual Meeting May 3, 2023
